Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection gains USFDA fast track… EP News Bureau Mar 28, 2025 Sanofi is planning a phase 1/2 randomised, clinical study designed to evaluate the immunogenicity and safety of the chlamydia…
